Solution

We’re bridging the gap between diagnostics and treatment

Functioning

Step into the future of patient-centered care

week 0
- Every Treatment Starts with a Question: Will It Work?
  
  A patient is diagnosed with a tumor and begins immunotherapy - a treatment designed to empower the immune system to fight the cancer.
week 2-4
- imuveo T-Cell Tracer Administered - Precision Diagnostics in Action
  
  The tracer binds to T cells and, thanks to its radioactive isotope, makes them visible in PET scans - offering a clear diagnostic advantage.
1h after patient received CD2-Tracer
- One Scan. Clearer Answers.
  
  The PET scan shows whether the treatment is working: if the tracer appears at the tumor, it's a good sign — it means T cells have reached the tumor. If not, i other treatment options can be explored.

Benefits

Faster Decisions. Lower Costs. Smarter Innovation.

01

Less waiting. More healing.

When therapy doesn’t work, we make sure patients switch sooner — saving time, cost, and harm.
02

Smarter Diagnostics, Lower Healthcare Costs

Lower costs mean more access to life-changing immunotherapies.
03

Smarter data. Faster drug development

Accelerate drug development while reducing trial time and costs.

Support us

Unlock the power of T-cell imaging - whether you're investing or innovating.

Shape the future of immunotherapy - join us in setting a new standard and backing our Phase 1 trial, as partner or investor.

learn more

The ecosystem is established and key players see the potential.
Every step along the way adds value to our project – and increases your ROI.
Boost your preclinical pipeline -add value to your biotech or pharma projects with precise T-cell tracking.

In detail

The smallest antibody with the biggest upsides.

From bloodstream to tumor in just one hour - our small tracer brings fast infiltration, strong binding, and early answers for patients and doctors.
Gallium-68: The perfect match for our single-domain antibody.

Protect patients, empower clinicians: With only 5 mSv radiation exposure and outstanding image quality, our tracer is globally accessible and ready for the clinic.
CD2 - One target to see all T cells.

We track all T-cells - and spotlight the ones truly attacking the tumor for more sensitive, efficient imaging

We make the invisible visible — delivering clear, fast, and precise insights into the immune response, so every patient gets the right treatment, at the right time.

Meet the team

Driven by science. United by purpose.

With expertise across science, clinic, and biotech economics, we are building a robust pipeline of novel PET tracers and radiopharmaceuticals. We are committed to leading the next generation of precision imaging - delivering both immediate solutions and long-term value for healthcare and investors.

about us